Vimarsana
Biggest News Aggregation in the World

Page 2 - Greg Canter News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Greg Canter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Greg Canter Today - Breaking & Trending Today

ALS Drug Gets Support of FDA Advisers in Rare Second Review - Vimarsana News

ALS Drug Gets Support of FDA Advisers in Rare Second Review

A closely watched experimental drug for Lou Gehrig’s disease got an unusual second look from U.S. regulators on Wednesday, following intense pressure to...

FDA panel backs Mass. company's ALS drug in rare, 2nd review - Vimarsana News

FDA panel backs Mass. company's ALS drug in rare, 2nd review

The Food and Drug Administration is not required to follow the panel's advice, but its positive recommendation suggests an approval is likely later this month.

Source: wcvb.com
FDA panel backs much-debated ALS drug in rare, 2nd revi... - Vimarsana News

FDA panel backs much-debated ALS drug in rare, 2nd revi...

A panel of federal health advisers has voted to recommend approval for an experimental drug to treat Lou Gehrig’s disease

FDA panel backs much-debated ALS drug in rare 2nd review - Vimarsana News

FDA panel backs much-debated ALS drug in rare 2nd review

A panel of federal health advisers has voted to recommend approval for an experimental drug to treat Lou Gehrig's disease. The ruling Wednesday is a remarkable turnaround for the much-debated medication that was previously rejected by the same group earlier this year. The FDA previously held a meeting in March where the outside experts narrowly sided against Amylyx's drug, saying the company's data was unconvincing. Wednesday's meeting focused on new analyses which the company said strengthened its case for approval. Patients and their families have rallied behind Amylyx's drug, urging approva...

Source: ksl.com
FDA panel backs much-debated ALS drug in rare review - Vimarsana News

FDA panel backs much-debated ALS drug in rare review

A panel of federal health advisers has voted to recommend approval for an experimental drug to treat Lou Gehrig's disease.